share_log

Summit Healthcare Acquisition (SMIH) and The Competition Critical Analysis

Summit Healthcare Acquisition (SMIH) and The Competition Critical Analysis

峰会医疗收购 (SMIH) 和竞争批判性分析
Financial News Live ·  2022/12/21 02:42

Summit Healthcare Acquisition (NASDAQ:SMIH – Get Rating) is one of 710 publicly-traded companies in the "Holding & other investment offices" industry, but how does it contrast to its competitors? We will compare Summit Healthcare Acquisition to similar businesses based on the strength of its valuation, profitability, institutional ownership, earnings, risk, analyst recommendations and dividends.

Summit Healthcare Accurition(纳斯达克股票代码:SMIH — Get Ratings)是 “控股和其他投资办公室” 行业的710家上市公司之一,但它与竞争对手的对比如何?我们将根据估值、盈利能力、机构所有权、收益、风险、分析师建议和股息的实力,将Summit Healthcare收购与类似业务进行比较。

Earnings and Valuation

收益和估值

This table compares Summit Healthcare Acquisition and its competitors gross revenue, earnings per share and valuation.

该表比较了Summit Healthcare收购及其竞争对手的总收入、每股收益和估值。

Get
获取
Summit Healthcare Acquisition
收购峰会医疗保健
alerts:
警报:
Gross Revenue Net Income Price/Earnings Ratio
Summit Healthcare Acquisition N/A -$550,000.00 12.59
Summit Healthcare Acquisition Competitors $1.72 billion $88.36 million 23.10
总收入 净收入 市盈率
收购峰会医疗保健 不适用 -550,000.00 美元 12.59
峰会医疗保健收购竞争对手 17.2 亿美元 8,836 万美元 23.10

Summit Healthcare Acquisition's competitors have higher revenue and earnings than Summit Healthcare Acquisition. Summit Healthcare Acquisition is trading at a lower price-to-earnings ratio than its competitors, indicating that it is currently more affordable than other companies in its industry.

Summit Healthcare Acquisition的竞争对手的收入和收益高Summit Healthcare Acquisition的交易市盈率低于竞争对手,这表明它目前比该行业的其他公司更实惠。

Volatility and Risk

波动性和风险

Summit Healthcare Acquisition has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500. Comparatively, Summit Healthcare Acquisition's competitors have a beta of 0.05, meaning that their average share price is 95% less volatile than the S&P 500.
Summit Healthcare收购的beta值为0.01,这意味着其股价的波动性比标准普尔500指数低99%。相比之下,Summit Healthcare Acquisition的竞争对手的beta值为0.05,这意味着他们的平均股价波动性比标准普尔500指数低95%。

Profitability

盈利能力

This table compares Summit Healthcare Acquisition and its competitors' net margins, return on equity and return on assets.

该表比较了Summit Healthcare收购及其竞争对手的净利润率、股本回报率和资产回报率。

Net Margins Return on Equity Return on Assets
Summit Healthcare Acquisition N/A 46.53% 8.78%
Summit Healthcare Acquisition Competitors 11.67% -68.35% 2.51%
净利润 股本回报率 资产回报率
收购峰会医疗保健 不适用 46.53% 8.78%
峰会医疗保健收购竞争对手 11.67% -68.35% 2.51%

Analyst Recommendations

分析师建议

This is a summary of recent ratings and target prices for Summit Healthcare Acquisition and its competitors, as provided by MarketBeat.com.

这是Marketbeat.com提供的Summit Healthcare Acquision及其竞争对手的最新评级和目标价格的摘要。

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Summit Healthcare Acquisition 0 0 0 0 N/A
Summit Healthcare Acquisition Competitors 113 593 889 18 2.50
卖出评级 保持收视率 买入评级 强劲的买入评级 评分分数
收购峰会医疗保健 0 0 0 0 不适用
峰会医疗保健收购竞争对手 113 593 889 18 2.50

As a group, "Holding & other investment offices" companies have a potential upside of 69.95%. Given Summit Healthcare Acquisition's competitors higher possible upside, analysts plainly believe Summit Healthcare Acquisition has less favorable growth aspects than its competitors.

作为一个整体,“控股和其他投资办公室” 公司的潜在上涨空间为69.95%。鉴于Summit Healthcare Acquisition的竞争对手可能更高的上行空间,分析师明确认为,Summit Healthcare

Institutional and Insider Ownership

机构所有权和内部所有权

64.3% of shares of all "Holding & other investment offices" companies are held by institutional investors. 17.6% of shares of all "Holding & other investment offices" companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

所有 “控股和其他投资办公室” 公司64.3%的股份由机构投资者持有。所有 “控股和其他投资办公室” 公司的17.6%的股份由内部人士持有。强大的机构所有权表明,捐赠基金、大型基金经理和对冲基金认为,从长远来看,公司的表现将超过市场。

Summary

摘要

Summit Healthcare Acquisition competitors beat Summit Healthcare Acquisition on 8 of the 10 factors compared.

在比较的10个因素中,Summit Healthcare收购的竞争对手击败了Su

Summit Healthcare Acquisition Company Profile

萨米特医疗收购公司简介

(Get Rating)

(获取评分)

Summit Healthcare Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2020 and is based in Central, Hong Kong.

Summit Healthcare Acquisity它打算与一个或多个企业或实体进行合并、股票交换、资产收购、股份购买、重组或类似的业务合并。该公司成立于 2020 年,总部位于香港中环。

Receive News & Ratings for Summit Healthcare Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Summit Healthcare Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.

每天接收有关收购 Summit Healthcare -在下面输入您的电子邮件地址,通过Marketbeat.com的免费每日电子邮件时事通讯接收Summit Healthcare Acquisition及相关公司的最新新闻和分析师评级的简明每日摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发